A Clinical Study Of Camrelizumab With Or Without Radiotherapy In The Treatment Of Esophageal Cancer
Clinical trial NCT04512417 · UNKNOWN
Trial details
- NCT number
- NCT04512417
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-31
- Primary completion
- 2021-08-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.